This is the authors' abstract. We don't add key points for this paper.
Background:Little is known about the dynamic changes in the patient immune responses to SARS-CoV-2, and how different responses are correlated with disease severity and outcomes.Method:A total of 74 patients with confirmed COVID-19 were included from January 29th to February 15 th 2020. Clinical characteristics and dynamic changes in immune response were analyzed and compared between severe and non-severe patients. ResultsOf the 74 patients, 17 suffered from severe disease and 57 from non-severe disease. Patients with severe disease tended be older (65.29 ± 12.33 years vs. 45.37 ± 18.66 years), and had a greater degree of underlying disease (41.18% vs. 24.56%) , lower lymphocytes counts (0.69 ± 0.36 × 10⁹ vs. 1.46 ± 0.75 × 10⁹) , higher neutrophil-lymphocyte-ratios (NLRs; 3.76 (3.15–5.51) vs. 2.07 (1.48–2.93)) and lower eosinophil counts (0.01 ± 0.01 × 10⁹ vs. 0.05 ± 0.07 × 10⁹), than that in non-severe patients. The number of immune cell subtypes, including helper T cells, suppressor T cells, B cells, and natural killer cells was significantly decreased in severe cases compared to that in non-severe cases (335.47 vs. 666.46/mL; 158 vs. 334/mL; 95 vs. 210/mL; 52 vs. 122/mL, respectively). As the condition of the patients improved, the number of neutrophils decreased significantly in the severe patients. All patients who recovered exhibited a gradual and persistent increase in eosinophil counts and lymphocyte counts, including helper T cells, suppressor T cells, and natural killer cells. In addition, the levels of most of inflammatory cytokines, including IFN-γ, IL-2, IL-4, IL-6, IL-10, IL-17A, and TNF–α generally decreased as the patients gradually recovered.ConclusionsCollectively, our study provides novel information on the kinetics of the immune responses to COVID-19. Furthermore, our study indicates that both innate and adaptive immune responses correlate with better clinical outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2020) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: